Belinda S. Parker

机构：The University of Melbourne, Peter MacCallum Cancer Centre · ORCID：0000-0002-8333-1926

发表论文 258 篇 · 总被引 7409 次 · h-index 39

代表论文

• Interferon-ε is a tumour suppressor and restricts ovarian cancer (2023 · Nature · 被引 73)
• The complexity of immune evasion mechanisms throughout the metastatic cascade (2024 · Nature Immunology · 被引 68)
• Lutetium-177 [177Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic castration-resistant prostate cancer (AlphaBet): an interim analysis of the investigator-initiated, single-centre, single-arm, phase 1/2 trial (2025 · The Lancet Oncology · 被引 19)
• Striking the right balance with type I interferon signalling in cancer (2026 · Nature reviews. Cancer · 被引 7)
• Investigating the Role of Heparanase in Breast Cancer Development Utilising the MMTV-PyMT Murine Model of Mammary Carcinoma (2023 · Cancers · 被引 4)
• Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer (2026 · Nature Communications · 被引 1)